Italy - Results from #100

Patients with cancer who will be cured and projections of complete prevalence in Italy from 2018 to 2030
Patterns of care and cost profiles of cancer patients in Italy: the EPICOST study
Patterns of care and cost profiles of cancer patients in Italy: the EPICOST study
Patterns of care and cost profiles of cancer patients in Italy: the EPICOST study
Patterns of Care and Cost Profiles of Women With Breast Cancer in Italy: EPICOST Study Based on Real World Data
Percorsi di cura e profili di costo di pazienti oncologici: lo studio Epicost
Performance of HPV E6/E7 mRNA Assay as Primary Screening Test. Results from the NTCC2 Trial
Pleural malignant mesothelioma epidemic: incidence, modalities of asbestos exposure and occupations involved from the Italian National Register
Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study
Problems, solutions and perspectives in the evaluation of interval cancers in Italian mammography screening programmes: a position paper from the Italian group for mammography screening (GISMa)
Prognosis and cure of long-term cancer survivors: A population-based estimation
Relationship between hospital volume and short-term outcomes: a nationwide population-based study including 75,280 rectal cancer surgical procedures
Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients
Report Mesoteliomi. Settembre 2023
Risk of CIN2 or more severe lesions after negative HPV-mRNA E6/E7 overexpression assay and after negative HPV-DNA test: Concurrent cohorts with a 5-year follow-up
Risk of COVID-19 hospitalization and mortality in rheumatic patients treated with hydroxychloroquine or other conventional DMARDs in Italy
Risk of thyroid as a first or second primary cancer. A population-based study in Italy, 1998-2012
Screening for colorectal cancer in Italy: 2011-2012 survey
Spatial assessment of incidence risk: comparison between MCMC and INLA methodologies in Bayesian hierarchical models
Stable prevalence of faecal immunochemical test positivity over time in Italy

Page 6 of 8